US$ 25.77
glp 1 agonist dpp 4 inhibitor GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician? Mechanism of action of DPP-4
Description
When combined with a caloric-deficient diet and exercise, it aids in weight loss and maintenance

SURMOUNT-4 will address the question of weight regain after stopping the drug: patients who took tirzepatide for 6 months, will be assessed for sustained weight loss one year later (NCT04660643)

Gromada, J., Holst, J

9-11 Hypoglycemia is something that patients fear, and this threat can lead to distrust or nonadherence to therapy

Add in targeted supplements (see below)
